Framingham Heart Study
Jump to navigation
Jump to search
In epidemiology, the Framingham Heart Study was a cohort study that started in 1948 for the objective of:[1]
- "The objective of the Framingham Heart Study was to identify the common factors or characteristics that contribute to CVD by following its development over a long period of time in a large group of participants who had not yet developed overt symptoms of CVD or suffered a heart attack or stroke."
The study was sponsored by the National Heart, Lung, and Blood Institute of the National Institutes of Health.
Research that has emerged from the study includes:
- Framingham risk score for events at 5[2] and 10[3][4] years
- Framingham congestive-heart-failure score
- Framingham atrial fibrillation risk
References
- ↑ History of the Framingham Heart Study
- ↑ D'Agostino RB, Grundy S, Sullivan LM, Wilson P, CHD Risk Prediction Group (2001). "Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.". JAMA 286 (2): 180-7. PMID 11448281. [e] Review in: ACP J Club. 2002 Jan-Feb;136(1):36
- ↑ Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998). "Prediction of coronary heart disease using risk factor categories.". Circulation 97 (18): 1837-47. PMID 9603539. [e]
- ↑ D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM et al. (2008). "General cardiovascular risk profile for use in primary care: the Framingham Heart Study.". Circulation 117 (6): 743-53. DOI:10.1161/CIRCULATIONAHA.107.699579. PMID 18212285. Research Blogging.